Paul Tudor Jones’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-22,589
| Closed | -$611K | – | 3216 |
|
|
2024
Q2 | $611K | Sell |
22,589
-118,586
| -84% | -$2.47M | ﹤0.01% | 1715 |
|
|
2024
Q1 | $2.59M | Buy |
141,175
+22,001
| +18% | +$349K | 0.02% | 900 |
|
|
2023
Q4 | $1.46M | Buy |
119,174
+53,776
| +82% | +$504K | 0.01% | 1265 |
|
|
2023
Q3 | $980K | Buy |
65,398
+51,904
| +385% | +$1.08M | 0.01% | 1309 |
|
|
2023
Q2 | $438K | Sell |
13,494
-46,144
| -77% | -$1.69M | 0.01% | 1788 |
|
|
2023
Q1 | $2.33M | Buy |
59,638
+16,961
| +40% | +$830K | 0.04% | 708 |
|
|
2022
Q4 | $2.25M | Buy |
+42,677
| New | +$2.08M | 0.04% | 572 |
|
|
2022
Q2 | – | Sell |
-9,314
| Closed | -$385K | – | 2600 |
|
|
2022
Q1 | $385K | Buy |
+9,314
| New | +$328K | 0.01% | 1422 |
|
|
2021
Q2 | – | Sell |
-34,149
| Closed | -$1.73M | – | 2019 |
|
|
2021
Q1 | $1.73M | Buy |
+34,149
| New | +$1.9M | 0.03% | 585 |
|
|
2020
Q4 | – | Sell |
-4,056
| Closed | -$273K | – | 1690 |
|
|
2020
Q3 | $273K | Buy |
+4,056
| New | +$221K | 0.01% | 1021 |
|
|
2020
Q1 | – | Sell |
-10,046
| Closed | -$406K | – | 1389 |
|
|
2019
Q4 | $406K | Buy |
+10,046
| New | +$352K | 0.02% | 784 |
|
Other funds holding SILK
Paul Tudor Jones's SILK Position: Q3 2024 in Review
Paul Tudor Jones sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 22,589 shares — an estimated $611K sold.
Paul Tudor Jones first reported a position in SILK in Q4 2019 and held it in 11 quarters. The position peaked at $2.59M in Q1 2024. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.
- Paul Tudor Jones reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
- Paul Tudor Jones sold 22,589 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $611K.
- Paul Tudor Jones first reported a position in Silk Road Medical, Inc. Common Stock in Q4 2019 and held it in 11 quarters.
- Paul Tudor Jones's Silk Road Medical, Inc. Common Stock position peaked at $2.59M in Q1 2024.
- 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.
Based on Tudor Investment Corp's 13F filing for Q3 2024, filed 14 Nov 2024.